ES2091766T3 - Uso de n-butil-desoxinojirimicina para el tratamiento de herpes. - Google Patents

Uso de n-butil-desoxinojirimicina para el tratamiento de herpes.

Info

Publication number
ES2091766T3
ES2091766T3 ES89870206T ES89870206T ES2091766T3 ES 2091766 T3 ES2091766 T3 ES 2091766T3 ES 89870206 T ES89870206 T ES 89870206T ES 89870206 T ES89870206 T ES 89870206T ES 2091766 T3 ES2091766 T3 ES 2091766T3
Authority
ES
Spain
Prior art keywords
treatment
desoxinojirimicina
herpes
butyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89870206T
Other languages
English (en)
Inventor
Gary Steven Jacob
Thomas William Rademacher
Albert Stanley Tyms
Raymond Allen Dwek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2091766T3 publication Critical patent/ES2091766T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LOS DERIVADOS N-ALQUIL DE 1,5-DIDEOXI-1,5-IMINO-D-GLUCITOL O SALES DERIVADAS FARMACEUTICAMENTE ACEPTABLES SON UTILES PARA FABRICAR UN MEDICAMENTO PARA EL TRATAMIENTO DE LOS VIRUS DEL HERPES.
ES89870206T 1988-12-22 1989-12-21 Uso de n-butil-desoxinojirimicina para el tratamiento de herpes. Expired - Lifetime ES2091766T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/288,528 US4957926A (en) 1988-12-22 1988-12-22 Method of treating herpesviruses

Publications (1)

Publication Number Publication Date
ES2091766T3 true ES2091766T3 (es) 1996-11-16

Family

ID=23107522

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89870206T Expired - Lifetime ES2091766T3 (es) 1988-12-22 1989-12-21 Uso de n-butil-desoxinojirimicina para el tratamiento de herpes.

Country Status (8)

Country Link
US (1) US4957926A (es)
EP (1) EP0378984B1 (es)
JP (1) JP2831068B2 (es)
AT (1) ATE142496T1 (es)
CA (1) CA2006267C (es)
DE (1) DE68927160T2 (es)
ES (1) ES2091766T3 (es)
GR (1) GR3021845T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
CN1074921C (zh) * 1994-01-13 2001-11-21 G·D·瑟尔公司 使用1,5－二脱氧－1,5－亚氨基－d－葡糖醇的n－烷基衍生物治疗乙型肝炎病毒感染
WO1995022975A1 (en) * 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
DK1030839T3 (da) 1997-11-10 2004-05-03 Searle & Co Anvendelse af alkylerede iminosukkere til behandling af multidrugresistens
US6809083B1 (en) 1998-02-12 2004-10-26 Richard A. Mueller Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
JP2002536407A (ja) * 1999-02-12 2002-10-29 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の治療のための置換−１，５−ジデオキシ−１，５−イミノ−ｄ−グルシトール化合物の使用
WO2001008672A2 (en) 1999-02-12 2001-02-08 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
WO2001060366A1 (en) * 2000-02-14 2001-08-23 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
JP4060079B2 (ja) 2000-03-31 2008-03-12 ミシガン ステイト ユニバーシティー オキシム又はイミンからの１，５―ジデオキシ―１，５−イミノヘキシトールの製法
PL2027137T3 (pl) 2005-06-08 2015-08-31 Amicus Therapeutics Inc Oczyszczanie imino- i aminocukrów
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
IT201700078102A1 (it) 2017-07-11 2019-01-11 Dipharma Francis Srl Sintesi di un azazucchero e suoi intermedi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis

Also Published As

Publication number Publication date
EP0378984A2 (en) 1990-07-25
US4957926A (en) 1990-09-18
DE68927160D1 (de) 1996-10-17
EP0378984B1 (en) 1996-09-11
DE68927160T2 (de) 1997-03-20
CA2006267C (en) 2000-05-02
ATE142496T1 (de) 1996-09-15
JPH02212430A (ja) 1990-08-23
JP2831068B2 (ja) 1998-12-02
GR3021845T3 (en) 1997-02-28
CA2006267A1 (en) 1990-06-22
EP0378984A3 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
ES2091766T3 (es) Uso de n-butil-desoxinojirimicina para el tratamiento de herpes.
LU90334I2 (fr) Raloxifene et ses sels et dérivés pharmaceutiquement acceptables
KR900009625A (ko) 피리미딘류 및 그의 약리학적으로 허용되는 염류 및 그 용도
RU95109100A (ru) Производные ксантина, смесь их изомеров или отдельные изомеры и их фармакологически переносимые соли и фармацевтическая композиция с антагонистической в отношении аденозина активностью на их основе
TJ249B (en) 1,3-Oxathiolane nucleoside analogues their use
DE69027235D1 (de) Xanthinderivate
PT89249A (pt) Processo para a preparacao de novos derivados de piperidinilo 1,4-dissubstituido com actividade terapeutica
NO172340C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 1,5-dideoxy-1,5-imino-(n-omega-methyl-caproat)-l-fucitol
FI893426A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten BU-3608-johdannaisten ja niiden suolojen valmistamiseksi
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
ES2061749T3 (es) Compuestos heterociclicos y agentes antiulcerosos.
DE68922035D1 (de) Glyzerin-Derivat und dessen pharmazeutische Verwendung.
DK79088A (da) 2-anilinothiazolinderivater eller farmaceutisk acceptable salte deraf samt deres anvendelse imod svampeinfektioner
DK47788D0 (da) 14,15-substituerede lanosteroler og fysiologisk acceptable salte deraf og deres anvendelse som farmaceutika
ES2169117T3 (es) Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano.
ES2061667T3 (es) Agente hipotensivo para el tratamiento o prevencion de la hipertension.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
EP0370821A3 (en) 1,4-dihydropyridine derivatives
DK530488D0 (da) 2,6-methanopyrrolo-3-benzazociner isomere, antipoder og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse samt mellemprodukter ved fremstillingen
ES2059181T3 (es) Uso de 1,4-dihidropiridinas para la fabricacion de un medicamento para el tratamiento de neuropatias causadas por diabetes mellitus.
AU8803091A (en) Method for protecting the myocardium against ischemia
IT9021767A0 (it) Composti a struttura triciclica n-metiltriptaminica per la terapia delle encefalopatie degenerative

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 378984

Country of ref document: ES